Senolytics are compounds that selectively eliminate senescent cells - damaged cells that have stopped dividing
but refuse to die. Often called "zombie cells," these dysfunctional cells accumulate with age and contribute to chronic inflammation,
tissue dysfunction, and accelerated aging.
As we age, our bodies accumulate senescent cells. While cellular senescence originally evolved as a tumor-suppression mechanism,
the persistence of these cells becomes problematic. Senescent cells secrete a cocktail of inflammatory molecules called the
Senescence-Associated Secretory Phenotype (SASP), which can damage neighboring healthy cells and tissues.
Key Research on Senolytics
- Mayo Clinic Studies: Pioneering research by Dr. James Kirkland showed that clearing senescent cells
extended healthspan in mice by 36%
and improved physical function.
- Unity Biotechnology: Human trials with pharmaceutical senolytics demonstrated
reduction in senescent cell markers
in patients with osteoarthritis.
- Fisetin Studies: A 2018 study in EBioMedicine
found fisetin was the most potent natural senolytic tested, extending lifespan in aged mice.
- Dasatinib + Quercetin: This combination was the first senolytic protocol tested in humans,
showing improved physical function
in patients with idiopathic pulmonary fibrosis.
Natural senolytics like fisetin and quercetin offer a more accessible approach than pharmaceutical options.
While research is still evolving, these compounds show promise for reducing senescent cell burden with a favorable safety profile.
For more on the science of cellular aging, see our guide on how to boost NAD+,
another key pathway in longevity.
Signs of Senescent Cell Accumulation
-
Increased inflammation markers
-
Slower recovery from exercise
-
Joint stiffness and discomfort
-
Reduced physical function
-
Skin aging and loss of elasticity
-
Metabolic dysfunction